Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Alx Oncology Holdings Inc (NASDAQ: ALXO) closed at $0.89 down -8.37% from its previous closing price of $0.97. In other words, the price has decreased by -$8.37 from its previous closing price. On the day, 2.72 million shares were traded. ALXO stock price reached its highest trading level at $0.98 during the session, while it also had its lowest trading level at $0.8.
Ratios:
For a deeper understanding of Alx Oncology Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.52 and its Current Ratio is at 4.52. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 06, 2025, Upgraded its rating to Buy and sets its target price to $3 from $2 previously.
On December 19, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $12 to $2.
Stifel Downgraded its Buy to Hold on March 08, 2024, whereas the target price for the stock was revised from $10 to $14.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 15 ’25 when Pinto Shelly sold 611 shares for $0.64 per share. The transaction valued at 391 led to the insider holds 89,198 shares of the business.
Lettmann Jason sold 2,382 shares of ALXO for $1,525 on Aug 15 ’25. The CHIEF EXECUTIVE OFFICER now owns 212,888 shares after completing the transaction at $0.64 per share. On Jul 07 ’25, another insider, Pinto Shelly, who serves as the SVP, FINANCE AND CAO of the company, sold 2,011 shares for $0.45 each. As a result, the insider received 905 and left with 86,809 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 47639056 and an Enterprise Value of -15492911.
Stock Price History:
The Beta on a monthly basis for ALXO is 1.08, which has changed by -0.644 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, ALXO has reached a high of $2.73, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is 63.05%, while the 200-Day Moving Average is calculated to be -5.65%.
Shares Statistics:
For the past three months, ALXO has traded an average of 774.14K shares per day and 2213870 over the past ten days. A total of 53.51M shares are outstanding, with a floating share count of 37.46M. Insiders hold about 30.04% of the company’s shares, while institutions hold 36.21% stake in the company. Shares short for ALXO as of 1753920000 were 4475437 with a Short Ratio of 5.78, compared to 1751241600 on 4874545. Therefore, it implies a Short% of Shares Outstanding of 4475437 and a Short% of Float of 13.340001.
Earnings Estimates
The company has 1.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$1.11 and -$1.11 for the fiscal current year, implying an average EPS of -$1.11. EPS for the following year is -$0.61, with 1.0 analysts recommending between -$0.61 and -$0.61.
